mjn-SERAS clinical trials

Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data

This study is testing a medical device called mjn-SERAS, designed to detect epileptic seizures early and give a warning. It's for people aged 12-65 in the UK, Spain, and Germany who have epilepsy that hasn't responded well to medication. The aim is to see if using the device improves their daily life.